Literature DB >> 7811874

The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research.

G W Comstock1.   

Abstract

If an American pediatrician's conversation with Dr. Johannes Holm, a Danish pathisiologist and future director of the International Tuberculosis Campaign, had not been interrupted, the campaign would probably not have become a monumental precedent for world health activities. The International Tuberculosis Campaign was conducted under the auspices of the United Nations International Children's Emergency Fund and three Scandinavian voluntary organizations. In a program that started in the war-torn areas of Europe, nearly 30 million persons underwent tuberculin testing, and almost 14 million were given BCG (bacille Calmette-Guérin) vaccine. In addition, a postgraduate school for physicians was initiated, new laboratories were established and old ones were improved, hundreds of young doctors and nurses were introduced to international public health, and, perhaps most important, research and service were successfully integrated. The success of the campaign led to its becoming the first major disease control and research activity of the World Health Organization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811874     DOI: 10.1093/clinids/19.3.528

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

Review 1.  Tuberculosis: 12. Global disease and the role of international collaboration.

Authors:  D A Enarson
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

2.  BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.

Authors:  Beatriz E Marciano; Chiung-Yu Huang; Gyan Joshi; Nima Rezaei; Beatriz Costa Carvalho; Zoe Allwood; Aydan Ikinciogullari; Shereen M Reda; Andrew Gennery; Vojtech Thon; Francisco Espinosa-Rosales; Waleed Al-Herz; Oscar Porras; Anna Shcherbina; Anna Szaflarska; Şebnem Kiliç; Jose L Franco; Andrea C Gómez Raccio; Persio Roxo; Isabel Esteves; Nermeen Galal; Anete Sevciovic Grumach; Salem Al-Tamemi; Alisan Yildiran; Julio C Orellana; Masafumi Yamada; Tomohiro Morio; Diana Liberatore; Yoshitoshi Ohtsuka; Yu-Lung Lau; Ryuta Nishikomori; Carlos Torres-Lozano; Juliana T L Mazzucchelli; Maria M S Vilela; Fabiola S Tavares; Luciana Cunha; Jorge A Pinto; Sara E Espinosa-Padilla; Leticia Hernandez-Nieto; Reem A Elfeky; Tadashi Ariga; Heike Toshio; Figen Dogu; Funda Cipe; Renata Formankova; M Enriqueta Nuñez-Nuñez; Liliana Bezrodnik; Jose Gonçalo Marques; María I Pereira; Viviana Listello; Mary A Slatter; Zohreh Nademi; Danuta Kowalczyk; Thomas A Fleisher; Graham Davies; Bénédicte Neven; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2014-04       Impact factor: 10.793

Review 3.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

Review 4.  Bacillus Calmette-Guerin (BCG): the adroit vaccine.

Authors:  Oluwafolajimi A Adesanya; Christabel I Uche-Orji; Yeshua A Adedeji; John I Joshua; Adeniyi A Adesola; Chibuike J Chukwudike
Journal:  AIMS Microbiol       Date:  2021-02-08

Review 5.  Addressing the Challenges of Tuberculosis: A Brief Historical Account.

Authors:  Hussam W Al-Humadi; Rafal J Al-Saigh; Ahmed W Al-Humadi
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

6.  The public perception of the value of vaccines - the case of Switzerland.

Authors:  Claire-Anne Siegrist; Marta A Balinska Peroutkova
Journal:  Z Gesundh Wiss       Date:  2008-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.